BSE filing, NSE: CITURGIBIO. Summary written from the filing by ALFA Finder's alert engine.
Citurgia Biochemicals Ltd: key numbers
- Share price
- ₹102.45
- Market cap
- ₹1,353 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.74 Cr
- P/E (TTM)
- -1827.2×Sector 34.1×
- Promoter holding
- 99.36%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Citurgia Biochemicals Ltd
All →Citurgia Biochemicals Other Announcement
Citurgia Biochemicals Ltd has submitted its quarterly shareholding pattern disclosure as required under Regulation 31(1)(b) of the SEBI Listing Regulations.
Citurgia Biochemicals Board Meeting Date
Citurgia Biochemicals announced a board meeting on October 6, 2026, to discuss scheduling the 51st Annual General Meeting and approving associated reports.
Citurgia Biochemicals Other Announcement
Citurgia Biochemicals Limited received approval from the Registrar of Companies for a one-month extension to hold its 51st Annual General Meeting by October 31, 2026.
Citurgia Biochemicals Management Change
Citurgia Biochemicals submitted the resignation letter of CS Yatendra Kumar, effective 24 July 2026. The filing rectifies a prior omission of the letter under Regulation 30 (LODR).
Citurgia Biochemicals Q1 FY27 Results: Net Loss of ₹0.1 Cr, Loss Widens
Citurgia Biochemicals Ltd reported a net loss of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.1 Cr
Citurgia Biochemicals Board Meeting Date
Citurgia Biochemicals Limited will hold a board meeting on August 12, 2026, to consider and approve standalone unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →Filtron Engineers Other Announcement
Filtron Engineers filed its Regulation 32 statement of deviations or variations for funds raised through a preferential issue for the quarter ended September 30, 2026. It reports no deviation, with Rs. 1,590 lakhs raised on 17/12/2025 and utilisation shown.
Bharti Hexacom Other Announcement
Bharti Hexacom informed the exchanges that its RTA, KFin Technologies, will move its corporate office effective December 1, 2026. The registered office of the RTA is unchanged.
Dr. Reddy's Laboratories Other Announcement
Dr Reddy's KMP Erez Israeli sold 460,276 ADRs to cover the exercise of 591,270 ADRs allotted under ESOP. The disposal is valued at about ₹61.76 Crore.
- Value
- ₹61.76 Cr
Addictive Learning Technology Other Announcement
Addictive Learning Technology filed its half-year IPO proceeds utilisation statement under Reg 32. Reallocations moved Rs.521.32 lakh to working capital, with Rs.200 lakh unused.
JSW Dulux Other Announcement
JSW Dulux Limited filed an Audio/Video Recording intimation dated 4 November 2026 with a link to its investor page. The filing carries no transaction, financial figures, or disclosed content of the call.
CLIO Infotech Other Announcement
Clio Infotech reported no deviation in its preferential issue fund utilisation for the quarter. Rs 3,17,145 of earlier unutilised funds were used during the period.